BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CMS, Inc. Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software


8/22/2008 8:27:53 AM

ST. LOUIS, Aug. 22 /PRNewswire/ -- CMS, Inc., an Elekta Company, and worldwide leader in radiation treatment planning and workflow management solutions, has received FDA 510(k) clearance for its new Atlas-Based Autosegmentation (ABAS) product. This clearance allows CMS to immediately begin distributing Atlas-Based Autosegmentation for clinical use in the United States.

Significantly reducing the amount of time spent creating and editing patient contours, ABAS is a software application that produces an estimate of the anatomy boundary contours needed to create a radiation treatment plan. Image segmentation, or contouring, is a time consuming component of the treatment planning process, and ABAS helps save clinicians time by providing a good starting point from which minimal editing is required.

In addition to its time-saving benefits, ABAS distinguishes itself from competing products in several ways. A stand alone, vendor neutral product that communicates using standard DICOM file formats for both input and output, ABAS is compatible with any radiation treatment planning system that can read standard DICOM RT structure set files. ABAS also provides structure specific refinement algorithms for head and neck treatments, as well as prostate treatments, in addition to a general algorithm that allows it to be used with other treatment sites.

"We are extremely proud and very pleased to receive clearance to distribute Atlas-Based Autosegmentation to the U.S. market," says Terry Wolf, Director of Research for CMS, an Elekta Company. "An embodiment of our core values, ABAS is an innovative solution delivered in a vendor-neutral platform aimed at improving the quality of care."

The ABAS algorithms were developed by Dr. Xiao Han, CMS Research Scientist. Dr. Han's work, titled, "Atlas-based Auto-segmentation of Head and Neck CT Images," will be presented September 9 at the 11th Annual International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) in New York City.

About CMS

CMS, Inc., an Elekta Company, is a worldwide market leader in radiation treatment planning and workflow management, combining innovative software applications and advanced technology tools to deliver comprehensive treatment planning and workflow management solutions that integrate seamlessly in any clinical environment. With a commitment to product excellence and a reputation for world-class service and support, CMS makes all members of the treatment team more effective in providing patient care.

CMS is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.

With more than 2,500 employees globally, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at www.cmsrtp.com and www.elekta.com .

CONTACT: Michelle Lee of Elekta, Inc., +1-770-670-2447,
michelle.lee@elekta.com, for CMS, Inc.

Web site: http://www.cmsrtp.com/
http://www.elekta.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES